Analyst Price Target is C$28.00
▲ +62.22% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Aurinia Pharmaceuticals in the last 3 months. The average price target is C$28.00, with a high forecast of C$28.00 and a low forecast of C$28.00. The average price target represents a 62.22% upside from the last price of C$17.26.
Current Consensus is
The current consensus among 2 contributing investment analysts is to buy stock in Aurinia Pharmaceuticals.